Athira Pharma, Inc. — Director's Dealing 2021

Nov 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2021-11-03

Reporting Person: Worthington Mark (General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-03	Stock Option (Right to Buy)	$15.34	A	150000	Acquired	2031-11-02	Common Stock (150000)	Direct

Footnotes

F1: One-fourth of the shares subject to the option vest on June 1, 2022 and one-fourth of the shares subject to the option vest on each subsequent anniversary thereafter.